Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 02-2013 | 12-2012 | 11-2012 | 08-2012 | 05-2012 | |
| Operating Expenses | 1,260 | 0 | 732 | 0 | 540 |
| Operating Income | -1,260 | N/A | -732 | N/A | -540 |
| Interest Expense | 33 | 0 | 299 | 0 | 10 |
| Other Income | 67 | 0 | 72 | 0 | 0 |
| Pre-tax Income | -1,226 | 0 | -959 | 0 | -550 |
| Net Income Continuous | -1,226 | N/A | -959 | N/A | -550 |
| Net Income | $-1,226 | $N/A | $-959 | $N/A | $-550 |
| EPS Basic Total Ops | -0.17 | N/A | -0.14 | N/A | -0.09 |
| EPS Basic Continuous Ops | -0.17 | N/A | -0.14 | N/A | -0.09 |
| EPS Diluted Total Ops | -0.17 | N/A | -0.14 | N/A | -0.09 |
| EPS Diluted Continuous Ops | -0.17 | N/A | -0.14 | N/A | -0.09 |
| EBITDA(a) | $-1,257 | $N/A | $-720 | $N/A | $-535 |